Pulmatrix Q1 EPS $(0.50) Down From $0.23 YoY

-2.25%

Pulmatrix Inc

PULM

0.00

Pulmatrix (NASDAQ: PULM) reported quarterly losses of $(0.50) per share. This is a 317.39 percent decrease over earnings of $0.23 per share from the same period last year.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

Pyxis Oncology Q3 EPS $(0.35) Misses $(0.34) Estimate

Biodexa Announces Approval Of Clinical Trial Application By European Medicines Agency For Phase 3 Serenta Trial

Eli Lilly Plans To Construct $3B Production Site In Katwijk, Netherlands

November 2025's Top Growth Companies With Insider Ownership

Ionis Pharmaceuticals (IONS): Assessing Valuation as Revenue Outlook Rises and Product Launches Accelerate

TuHURA Biosciences Files For Mixed Shelf Of Up To $250M

A Fresh Look at Jazz Pharmaceuticals (JAZZ) Valuation Following Landmark Settlement With Avadel

Expert Outlook: Liquidia Through The Eyes Of 7 Analysts